Results 101 to 110 of about 54,991 (287)

Ingesting Magic: Ingredients and Ecstatic Outcomes in the Greek and Demotic Magical Papyri [PDF]

, 2017
There are spells in the Greek and Demotic Magical Papyri which promise divine visitations, assistants, ecstatic states, vessel inquiries, and vivid dreams. They also require powerful psychoactive botanical ingredients.
Sumler, Alan
core  

Drug Critical Limits for Urgent Physician Notification

Clinical Pharmacology &Therapeutics, EarlyView.
Critical limits represent quantitative decision thresholds for drugs that require immediate clinician notification and potential life‐saving intervention. United States hospitals lack a national standard for drug critical limits. We collected critical limits from 417 US hospitals across all 50 states and Washington, D.C.; of these, 411 maintained drug ...
Elina Kuang, Yasmeen Ibrahim, Kyle Cheng, Gerald J. Kost   +3 more
wiley   +1 more source

Mapping Current and Potential Sources of Routine Data Capture on New Psychoactive Substances in Scotland [PDF]

, 2015
The paper maps the data currently being captured on NPS, and provides a starting point for exploring the strengths and weaknesses of a number of existing data systems in Scotland, and opportunities for data ...
Gillies, Allan
core  

New Psychoactive Substances: towards a conceptual delimitation

Análise Social, 2019
New Psychoactive Substances (NPS) are a relatively recent phenomenon characterized by continuous expansion throughout more or less the entire world in the last decade. They include a diversity of natural or synthetic substances that are not yet on official lists and whose great variety and rapid transformations make the NPS concept itself hard to ...
Susana Henriques, Maria das Dores Guerreiro, Joana Paula Silva   +2 more
openaire   +5 more sources

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Clinical Pharmacology &Therapeutics, EarlyView.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović, Kent W. Nilsson, Robert Fredriksson, Helgi B. Schiöth, Thiago C. Moulin   +4 more
wiley   +1 more source

A Novel Workflow for Fast Elucidation of Drug Metabolites for Screening—Combining In Silico Metabolite Prediction With Trapped Ion Mobility QTOF‐MS

Drug Testing and Analysis, EarlyView.
UHPLC‐timsTOF‐MS with in silico prediction and automated annotation enabled rapid identification of quetiapine metabolites from pHLMs, facilitating their inclusion in targeted LC‐QTOF‐MS urine screening and improving biomarker detection for toxicological applications.
Annette Zschiesche, Birgit Schneider, Ilona Nordhorn, Carsten Baessmann, Laura M. Huppertz, Jürgen Kempf   +5 more
wiley   +1 more source

A critical analysis of New Zealand's Psychoactive Substances Act 2013 and its implementation process : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Public Health at Massey University, Albany, New Zealand [PDF]

, 2017
Listed in 2017 Dean's List of Exceptional ThesesIntroduction: In July 2013, the New Zealand Parliament passed the Psychoactive Substances Act (PSA), the world’s first law to regulate the availability of new psychoactive substances (NPS, “legal highs ...
Rychert, Marta
core  

Effect of Reaction Time and Temperature on the Impurity Profile of Amphetamine in the Leuckart Method

Drug Testing and Analysis, EarlyView.
This study investigates the effect of the reaction temperature (step 1) and reaction time (step 1 and 2) on the conversion efficiency and impurity profile of amphetamine synthesized via the Leuckart method. Conversion efficiency and impurity profile were assessed using gas chromatography–flame ionization detection (GC–FID) and GC–mass spectrometry (GC ...
Maartje C. M. Verhoeven, Robert C. Huls, Nelly W. van der Stelt, Jelle C. de Koning, Marco van Grol, Ruben F. Kranenburg, Arian C. van Asten, Janneke W. Hulshof   +7 more
wiley   +1 more source

Identification and Characterization of the Designer Opioid N‐Pyrrolidino Fluetonitazene in Nasal Spray

Drug Testing and Analysis, EarlyView.
N‐Pyrrolidino fluetonitazene, a synthetic opioid, was identified and characterized in a nasal spray using GC‐MS, LC‐QTOF‐MS, NMR and FT‐IR. ABSTRACT Detection of drugs in non‐biological samples serves as a fundamental basis for identifying emerging trends in the field of new psychoactive substances and provides valuable information for optimizing ...
Fabian Picht, Valentin Cepus, Rona Hohlfeld, Julian Klingbeil, Marco Weber   +4 more
wiley   +1 more source

Updating your drugs policy to include NPS. [PDF]

, 2017
In previous briefing papers, Mentor looked at the impact of new psychoactive substances on public health and drugs education. Schools and practitioners should also update their drugs policy to take account of New Psychoactive Substances (NPS).

core